Results 91 to 100 of about 2,141 (223)

Colonic Diffuse Large B-Cell Lymphoma in a Liver Transplant Patient with Historically Very Low Tacrolimus Levels

Case Reports in Transplantation, 2012
Posttransplant lymphoproliferative disorders (PTLDs) comprise a wide spectrum of hematologic malignancies that are found increasingly in orthotopic liver transplant (OLT) patients given the rising frequency of these surgeries and their long-term success.
Christopher M. Moore, Ihab Lamzabi, Anne K. Bartels, Shriram Jakate, David H. Van Thiel   +4 more
doaj   +1 more source

Post transplant lymphoproliferative disorder [PDF]

, 2013
Introduction: Post-transplant lymphoproliferative disorder (PTLD) is a recognized complication exclusive to solid organ transplant recipients and carries a high mortality.
Cader, Rizna Abdul, Gafor, Halim Abdul, Kong, Norella CT, Mohd, Rozita   +3 more
core   +1 more source

Primary adult liver transplantation under tacrolimus: More than 90 months actual follow-up survival and adverse events [PDF]

, 1999
The introduction of tacrolimus has shown decreased rates of acute and steroid-resistant rejection after liver transplantation (LTx). The aim of the present study is to examine the long-term efficacy and safety of tacrolimus in primary liver transplant ...
Fung, JJ, Jain, AB, Kashyap, R, Rakela, J, Starzl, TE   +4 more
core   +1 more source

Peritoneal Lymphomatosis as Posttransplant Lymphoproliferative Disorder

eJHaem, Volume 7, Issue 2, April 2026.
Shiori Nishitani, Kumiko Kagawa, Makiko Mizuguchi, Tomoko Maruhashi, Hironobu Shibata, Motoko Sei, Tamotsu Tojimbara, Shuji Ozaki   +7 more
wiley   +1 more source

Influence of induction therapy, immunosuppressive regimen and anti-viral prophylaxis on development of lymphomas after heart transplantation: data from the spanish post–heart transplant tumour registry [PDF]

, 2007
[Abstract] Background. Lymphoma after heart transplantation (HT) has been associated with induction therapy and herpesvirus infection. It is not known whether anti-viral agents administered immediately after HT can reduce the incidence of lymphoma ...
Almenar, Luis, Alonso-Pulpón, Luis, Arizón-del-Prado, José M., Blasco, Teresa, Campreciós, Marta, Crespo-Leiro, María Generosa, Delgado-Jiménez, Juan F., Díaz, Beatriz, Fuente, Luis de la, Lage, Ernesto, Manito, Nicolás, Muñiz, Javier, Palomo, Jesús, Pascual, Domingo, Roig, Eulàlia, Rábago, Gregorio, Vázquez de Prada, José A.   +16 more
core   +2 more sources

Immunophenotipic and molecular characterization of EBV-driven age-related lymphoproliferative disorders [PDF]

, 2013
Based on epidemiological studies, EBV-positive lymphoproliferative disorders (LPD) are associated with patient’s age, immune system status of the host, geography, and socioeconomic conditions.
DI NAPOLI, ARIANNA
core   +3 more sources

Small-Sized Clone of T Cells in Multiple Myeloma Patient after Auto-SCT: T-LGL Leukemia Type or Clonal T-Cell Aberration?

Case Reports in Hematology, 2013
Second cancers and particularly postransplant lymphoproliferative disorders (PTLDs) are extremely rare in patients undergoing autologous peripheral blood stem cell transplantation (auto-SCT).
Giuseppe Mele, Marilena Greco, Maria Rosaria Coppi, Giacomo Loseto, Angela Melpignano, Salvatore Mauro, Gianni Quarta   +6 more
doaj   +1 more source

Identification of protein kinase inhibitors with a selective negative effect on the viability of Epstein-Barr virus infected B cell lines [PDF]

, 2014
Epstein-Barr virus (EBV) is a human herpesvirus, which is causally associated with the development of several B lymphocytic malignancies that include Burkitt's lymphomas, Hodgkin's disease, AIDS and posttransplant associated lymphomas.
Kéri György, Mavromatidis V, Mosialos G, Orfi Z, Varga Z, Wáczek Frigyes, Őrfi László   +6 more
core   +3 more sources

Immune‐related toxicity profile after haematopoietic stem cell transplantation in patients with B‐ALL given combination immunotherapy with rituximab, inotuzumab and blinatumomab

British Journal of Haematology, Volume 208, Issue 4, Page 1462-1466, April 2026.
Olayinka Okeleji, David McCall, Branko Cuglievan, Amber Gibson, Demetrios Petropoulos, Priti Tewari, Jeremy Connors, Irtiza N. Sheikh   +7 more
wiley   +1 more source

EBV-Negative Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder with Marked Morphologic Pleomorphism and Pathogenic Mutations in ASXL1, BCOR, CDKN2A, NF1, and TP53

Case Reports in Hematology, 2017
Posttransplant lymphoproliferative disorders (PTLDs) are a diverse group of lymphoid or plasmacytic proliferations frequently driven by Epstein-Barr virus (EBV). EBV-negative PTLDs appear to represent a distinct entity.
Agata M. Bogusz
doaj   +1 more source